Sponsor:
Insmed Incorporated
Code:
NCT07481981
Conditions
Pulmonary Arterial Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Treprostinil Palmitil Inhalation Powder
Placebo
Brief summary:
Conditions
Pulmonary Arterial Hypertension
Study ID
NCT07481981
Start date
Jul 21, 2026
Status verified date
Oct, 2026
Completion date
Jan 28, 2029
Anticipated
Primary completion date
Dec 28, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
344 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Treprostinil Palmitil Inhalation Powder
placebo comparator: Placebo
Interventions
Treprostinil Palmitil Inhalation Powder
Placebo
Primary outcome measure
Central contacts
Locations
USA012
Recruiting
Los Angeles, California, United States, 90027
USA008
Recruiting
Santa Barbara, California, United States, 93105
USA005
Recruiting
Torrance, California, United States, 90502
USA010
Recruiting
Kansas City, Kansas, United States, 66160
USA028
Recruiting
Omaha, Nebraska, United States, 68198-6450
USA022
Recruiting
New Hyde Park, New York, United States, 11042
USA011
Recruiting
New York, New York, United States, 10016
USA015
Recruiting
New York, New York, United States, 10075
USA013
Recruiting
Rochester, New York, United States, 14642
USA006
Recruiting
Philadelphia, Pennsylvania, United States, 19140
USA007
Recruiting
Anderson, South Carolina, United States, 29621
Sponsor
Insmed Incorporated
Last update posted
Oct 13, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Insmed Incorporated on 2026-10-13. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.